Monday Basic Early Morning Workshops EMW-15 Macrophage Polarization Cell Cycle inhibitor in Liver Disease Laura E. Nagy, PhD and Costica Aloman, MD EMW-16 Animal Models
of PBC M. Eric Gershwin, MD and Juan F. Medina, MD, PhD EMW-17 Mechanisms of Drug-induced Liver Injury Hartmut Jaeschke, PhD and John J. Lemasters, MD, PhD EMW-18 Roles of Autophagy in Liver Pathophysiology Mark J. Czaja, MD and Wen-Xing Ding, PhD EMW-19 Inflammasome Involvement in Liver Disease Gyongyi Szabo, MD, PhD and Wajahat Z. Mehal, MD EMW-20 Role of MicroRNAs in Liver Disease Joshua Friedman, MD, PhD and Kalpana Ghoshal, PhD Monday Clinical Early Morning Workshops EMW-21 Controversies in Management of PSC Jayant A. Talwalkar, MD and Roger W. Chapman, MD, PhD EMW-22 Who and How to Screen for Wilson Disease Peter Ferenci, MD and Frederick K. Askari, MD, PhD EMW-23 Acute on Chronic Liver Failure: An Update K. Rajender Reddy, MD and Rajiv Jalan, Doxorubicin MD, PhD EMW-24 Emerging Therapies for Management of NASH Naga P. Chalasani, MD and Vlad Ratziu, MD EMW-25 Management of HIV/HCV Co-infection in the DAA Era Mark S. Sulkowski, MD and Richard K. Sterling, MD, MSc EMW-26 HCV: Management of Non-responders including DAA Marc G. Ghany, MD and Gregory T. Everson, MD EMW-27 Beneficial Effects of Coffee Consumption in Liver Disease Kiran Bambha, MD and Dawn M. Torres, MD EMW-28
Are Patients With Chronic Liver Disease At Greater Risk Of Drug-Induced Liver Injury? Paul B. Watkins, MD and Robert J. Fontana, MD Poster Session III Monday, MCE November 4 8:00 AM – 5:30 PM Hall E Refer to page 149 for Poster Presentations Exhibit Hall Monday, November 4 9:30 AM – 3:00 PM Hall D Plenary Session Presidential Plenary: Scientific Advances in Hepatology Monday, November 4 8:00 – 9:30 AM Hall E/General Session MODERATORS: Ronald J. Sokol, MD J. Gregory Fitz, MD 8:00 AM 103: Interleukin-33 Induces a Potent Cholangiocyte Proliferation via
a Novel Paracrine Circuit Jun Li, Pranavkumar Shivakumar, Stephanie Walters, Tatsuki Mizuochi, Reena Mourya, Kazuhiko Bessho, Jorge A. Bezerra 8:15 AM 104: Signaling via the osteopontin and high-mobility group box-1 axis drives the fibrogenic response to liver injury Elena Arriazu, Xiaodong Ge, Tung Ming Leung, Aritz Lopategi, Yongke Lu, Naoto Kitamura, Raquel Urtasun, Neil D. Theise, Natalia Nieto 8:30 AM 105: Cell Fate Tracking Reveals Hepatocytes as the Primary Cellular Source for Hepatocellular Carcinoma Regina Español Suñer, Xueru Mu, Christine Sempoux, Dianne H. Dapito, Frederic Lemaigre, Isabelle A. Leclercq, Robert Schwabe 8:45 AM 106: The mast cell stabilizer, cromolyn sodium, reduces bile duct ligated-induced biliary hyperplasia: a novel role for the in vivoparacrine influence of mast cells on biliary proliferation Laura Hargrove, Lindsey Kennedy, Taylor Francis, Kyle M. Hodges, Allyson B. Graf, Yoshiyuki Ueno, John F. Greene, Heather L.